- Ardelyx, Inc.
$50 Million - Follow-OnJoint Bookrunner
- AxoGen, Inc.
$141 Million - Follow-OnJoint Bookrunner
- ASLAN Pharmaceuticals Limited
$42 Million - Initial NASDAQ ListingJoint Bookrunner
- SIEN / A Come-Back Story In The Making; Resuming Coverage With Outperform & $19 Price Target
- Healthcare Facilities / Selective Stock-Picking Is Key; Not Secular Volume Rebound: Buy HCA, THC, UHS
- A / Site Visit Highlights Efforts to Drive Value to Customers and Gain Market Share / Outperform